Fluorouracil Tied to Reduced Surgery for Squamous Cell CA

Share this content:
Fluorouracil Tied to Reduced Surgery for Squamous Cell CA
Fluorouracil Tied to Reduced Surgery for Squamous Cell CA

FRIDAY, Jan. 5, 2018 (HealthDay News) -- Fluorouracil application can reduce the risk of surgery for squamous cell carcinoma for one year among patients with a history of keratinocyte carcinomas, according to a study published online Jan. 3 in JAMA Dermatology.

Martin A. Weinstock, M.D., Ph.D., from the Veterans Affairs Medical Center in Providence, R.I., and colleagues randomized 932 veterans with a history of at least two keratinocyte carcinomas in the past five years to applications of fluorouracil, 5 percent (468 patients), or vehicle control cream (464 patients) to the face and ears twice daily for two to four weeks.

The researchers found that over four years, 299 patients developed a basal cell carcinoma end point and 108 developed a squamous cell carcinoma end point. There was no difference between the treatment groups in the time to first keratinocyte, basal cell, or squamous cell carcinoma over the entire study. During the first year, 1 and 4 percent of patients in the fluorouracil and control groups developed a squamous cell carcinoma, respectively (75 percent risk reduction; 95 percent confidence interval, 35 to 91 percent; P = 0.002). The 11 percent reduction in basal cell carcinoma risk during the first year in the fluorouracil group was not significant, and there was not a significant effect on keratinocyte carcinoma risk.

"A conventional course of fluorouracil to the face and ears substantially reduces surgery for squamous cell carcinoma for one year," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Pharmacist Participation in Stroke Response Cuts DoorNeedle Time

Pharmacist Participation in Stroke Response Cuts Door➜Needle Time

Pharmacist helps reduces DTN time by median 23.5 min; ups percent of patients meeting ≤60 min goal

Risk of Psychotic Experiences Up With Teen Cannabis Use

Risk of Psychotic Experiences Up With Teen Cannabis ...

Risk also increased with early-onset cigarette-only use, but correlation attenuated after adjustment

Reminder, Recall Systems Improve Immunization Uptake

Reminder, Recall Systems Improve Immunization Uptake

Based on high certainty evidence, postcards, text messages, auto-dialer improve receipt of vaccines

is free, fast, and customized just for you!

Already a member?

Sign In Now »